North America Glucose Monitoring Devices Market – Industry Trends and Forecast to 2028

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

North America Glucose Monitoring Devices Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Reports
  • Sep 2021
  • North America
  • 150 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

North America Glucose Monitoring Devices Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2022 –2028
Diagramm Marktgröße (Basisjahr)
MILLIONEN USD
Diagramm Marktgröße (Prognosejahr)
MILLIONEN USD
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • DiaMonTech AG
  • Medtronic
  • Abbott
  • Dexcom
  • F. Hoffmann-La Roche Ltd

North America Glucose Monitoring Devices Market, By Product Type (Self-Monitoring Blood Glucose Devices and Continuous Glucose Monitoring Devices), Distribution Channel (Retail and Online), End User (Hospital, Clinics, Diagnostic Centres, Home Healthcare and Others), Country (U.S., Canada and Mexico) Industry Trends and Forecast to 2028

North America Glucose Monitoring Devices Market

Market Analysis and Insights of Glucose Monitoring Devices Market

Data Bridge Market Research analyses that the North America glucose monitoring devices market will exhibit a CAGR of around 8.71% for the forecast period of 2021-2028. Rising awareness about the self-management of diabetes, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies, ever-rising geriatric population base and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of glucose monitoring devices market.

From the name itself, it is clear that glucose monitoring devices are the medical instruments that are used to monitor the level of glucose in the body. Apart from just keeping a track of blood glucose levels, the glucose monitoring devices help to maintain a balance between food and exercise. The glucose monitoring devices are available in the form of lancets, testing strips and glucose meters. These are convenient in handling and portable in nature.

Upsurge in the prevalence of diabetes globally are the major factors fostering the growth of the market. Rising focus on the healthcare technological advancements coupled with presence of supportive regulatory and beneficial policies is another market growth determinant. Rising number of hospitals and diagnostic centres, surging obesity and ever-rising geriatric population will further generate lucrative market growth opportunities.

However, high costs associated with frequent blood glucose tests and maintaining the devices will derail the market growth rate. Lack of medical experts especially in the developing and underdeveloped economies and less focus on promotional campaigns will further pose challenges for the market.  Also, manufacturing defects in the machines will also hamper the market growth rate.

This glucose monitoring devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on glucose monitoring devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Glucose Monitoring Devices Market Scope and Market Size

The North America glucose monitoring devices market is segmented on the basis of product type, distribution channel and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product type, the glucose monitoring devices market is segmented into self-monitoring blood glucose devices and continuous glucose monitoring devices. Self-monitoring blood glucose devices have further been segmented into glucose strips, glucose meter and lancets.
  • The distribution channel of the glucose monitoring devices market is segmented into retail and online. Retail has further been segmented into specialty stores and drug stores/pharmacies.
  • On the basis of end user, the glucose monitoring devices market is segmented into hospitals, clinics, diagnostic centers, home healthcare and others.

North America Glucose Monitoring Devices Market Country Level Analysis

The North America glucose monitoring devices market is analysed and market size insights and trends are provided by country, product type, distribution channel and end user as referenced above.

The countries covered in the glucose monitoring devices market report are U.S., Canada and Mexico.

United States dominates the North America glucose monitoring devices market in terms of market share and market revenue. This is because of the prevailing advanced healthcare technologies and prevalence of major players in this region. Ever-rising geriatric population, high incidences of diabetes and growing obese and overweight population base are some other market growth determinants for this region.

The country section of the North America glucose monitoring devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

The North America glucose monitoring devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America glucose monitoring devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America glucose monitoring devices market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Glucose Monitoring Devices Market Share Analysis

The North America glucose monitoring devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to North America glucose monitoring devices market.

The major players covered in the North America glucose monitoring devices market report are DiaMonTech AG, Medtronic, Abbott, Dexcom, Inc., F. Hoffmann-La Roche Ltd, 77 Elektronika Kft., GlySens Incorporated., Novo Nordisk A/S, Beurer GmbH, Nemaura., PHC Holdings Corporation, Senseonics, Ascensia Diabetes Care Holdings AG., AgaMatrix, Nova Biomedical, ACON Laboratories, Inc., HemoCue India, Danaher., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

United States is the dominating region of the Glucose Monitoring Devices Market.
The North America Glucose Monitoring Devices Market growth rate will be 8.71% by 2028.
Rising focus on the healthcare technological advancements coupled with presence of supportive regulatory and beneficial policies are the growth drivers of the North America Glucose Monitoring Devices Market.
The product type, distribution channel and end user are the factors on which the North America Glucose Monitoring Devices Market research is based.
The major companies in the North America Glucose Monitoring Devices Market are DiaMonTech AG, Medtronic, Abbott, Dexcom, Inc., F. Hoffmann-La Roche Ltd, 77 Elektronika Kft., GlySens Incorporated., Novo Nordisk A/S, Beurer GmbH, Nemaura., PHC Holdings Corporation, Senseonics, Ascensia Diabetes Care Holdings AG., AgaMatrix, Nova Biomedical, ACON Laboratories, Inc., HemoCue India, Danaher.